Jessica Camara, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 677 Main Rd, Tiverton, RI 02878 Phone: 401-624-8411 |
Dr. Dena Peltier, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 677 Main Rd, Tiverton, RI 02878 Phone: 401-624-8411 |
Susan Cheryl Patota, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 Main Rd, Tiverton, RI 02878 Phone: 401-624-8421 Fax: 401-624-1298 |
Riwa Khoury, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 677 Main Rd, Tiverton, RI 02878 Phone: 401-624-8411 |
Rachel Grant Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 Main Rd, Tiverton, RI 02878 Phone: 401-624-8421 |
Ms. Victoria A Morro, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 677 Main Rd, Tiverton, RI 02878 Phone: 401-624-8411 Fax: 401-625-1281 |
Andrew W Sampaio Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 Main Rd, Tiverton, RI 02878 Phone: 401-624-8421 Fax: 401-624-1298 |
Justin M Costa Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 677 Main Rd, Tiverton, RI 02878 Phone: 401-624-8411 |
News Archive
Aeterna Zentaris Inc. today announced that Phase 1 trial results for its oral PI3K/Akt inhibitor, perifosine, showed the drug's activity against chemo-resistant and radio-resistant neuroblastoma, while allowing good quality of life and sparing vital organs. Neuroblastoma is a type of childhood cancer which usually begins in nerve tissues.
Childhood physical abuse is associated with significantly elevated rates of functional somatic syndromes such as chronic fatigue syndrome, fibromyalgia and multiple chemical sensitivities among women, according to new findings by University of Toronto researchers.
A state review finds Minnesota HMOs providing services to public programs such as Medicaid and MinnesotaCare have generally sound financial practices. But the report did raise concerns about the plans' charitable donations and other uses of public dollars.
A new study has shown that Ebola survivors may be at risk of severe vision loss or blindness weeks after being declared virus-free. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology this week in Seattle, Wash.
The Kaiser Family Foundation's monthly tracking poll found that 47 percent of the uninsured said they have unfavorable views of the law - an increase since December. Most were also unaware of many of the law's benefits.
› Verified 3 days ago